Characteristics of the chemotactic response of neoplastic cells to a factor derived from the fifth component of complement.

Chemotactic factors for malignant neoplastic cells can be generated from either the fifth component of complement or from leukotactic fractions obtained from zymosanactivated serum. Digestion of the fifth component of complement by trypsin initially produced leukotactic activity, but as digestion continues, leukotactic activity is lost and tumor cell chemotactic activity is generated. Separation of the leukotactic activity is lost and tumor cell chemotactic activity is generated. Separation of the leukotactic activity and tumor cell chemotactic activity can be accomplished by gel filtration or isoelectric focusing. Gel filtration indicates that the tumor cell chemotactic factor has a molecular weight of approximately 8000 daltons. Tumor cell chemotactic activity can be generated by trypsinizing the leukotactic fractions isolated by isoelectric focusing. The responses of cultured Walker tumor cells or of Walker ascites tumor cells are dose-dependent and truly chemotactic. Cells from a murine malignant lymphoma do not respond to the complement-derived chemotactic factor for tumor cells, indicating that not all malignant cells share this functional property.

[1]  R. Snyderman,et al.  Biologic and biochemical activities of continuous macrophage cell lines P388D1 and J774.1. , 1977, Journal of immunology.

[2]  J. Gallin,et al.  Interaction of chemotactic factors with human macrophages: induction of transmembrane potential changes , 1977, The Journal of cell biology.

[3]  H. Hayashi,et al.  Characterization of two different factors chemotactic for cancer cells from tumor tissue , 1976, Virchows Archiv. B, Cell pathology.

[4]  P. Ward,et al.  A unique complement derived chemotactic factor for tumor cells. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[5]  B. Radola.  Isoelectric focusing in layers of granulated gels. II. Preparative isoelectric focusing. , 1975, Biochimica et biophysica acta.

[6]  P. Ward,et al.  Two distinct chemotactic factor inactivators in human serum. , 1975, Journal of immunology.

[7]  Sally H. Zigmond,et al.  Leukocyte locomotion and chemotaxis. New methods for evaluation, and demonstration of a cell-derived chemotactic factor. , 1973 .

[8]  U. Nilsson,et al.  Additional studies on human C5: development of a modified purification method and characterization of the purified product by polyacrylamide gel electrophoresis. , 1972, Immunochemistry.

[9]  H. Hayashi,et al.  Studies on the mechanisms of invasion in cancer. II. In vivo effects of a factor chemotactic for cancer cells , 1971, International journal of cancer.

[10]  H. Hayashi,et al.  Studies on the mechanisms of invasion in cancer. I. Isolation and purification of a factor chemotactic for cancer cells , 1970, International journal of cancer.

[11]  H. Hayashi,et al.  Chemotactic Factor associated with Invasion of Cancer Cells , 1970, Nature.

[12]  P. Ward,et al.  Bacterial factors chemotactic for polymorphonuclear leukocytes. , 1968, The American journal of pathology.

[13]  P. Andrews,et al.  Estimation of the molecular weights of proteins by Sephadex gel-filtration. , 1964, The Biochemical journal.

[14]  Z. Cohn,et al.  INTERACTIONS BETWEEN RABBIT POLYMORPHONUCLEAR LEUCOCYTES AND STAPHYLOCOCCI , 1959, The Journal of experimental medicine.

[15]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[16]  P. Ward,et al.  A comparison of the migration patterns of normal and malignant cells in two assay systems. , 1978, The American journal of pathology.

[17]  Ward Pa,et al.  Further studies on the C5-derived chemotactic factor for tumor cells. , 1976 .

[18]  P. Wilkinson,et al.  Recognition in leucocyte chemotaxis. Studies with structurally modified proteins. , 1974, Antibiotics and chemotherapy.